- Home
- MXL vs TVTX Comparison
MXL vs TVTX Comparison
Compare MXL & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MXL
- TVTX
- Stock Information
- Founded
- MXL 2003
- TVTX 2008
- Country
- MXL United States
- TVTX United States
- Employees
- MXL N/A
- TVTX N/A
- Industry
- MXL Semiconductors
- TVTX Biotechnology: Pharmaceutical Preparations
- Sector
- MXL Technology
- TVTX Health Care
- Exchange
- MXL Nasdaq
- TVTX Nasdaq
- Market Cap
- MXL 1.7B
- TVTX 1.8B
- IPO Year
- MXL 2010
- TVTX N/A
- Fundamental
- Price
- MXL $16.60
- TVTX $21.98
- Analyst Decision
- MXL Buy
- TVTX Strong Buy
- Analyst Count
- MXL 7
- TVTX 12
- Target Price
- MXL $25.58
- TVTX $30.08
- AVG Volume (30 Days)
- MXL 2.4M
- TVTX 1.9M
- Earning Date
- MXL 01-29-2025
- TVTX 02-20-2025
- Dividend Yield
- MXL N/A
- TVTX N/A
- EPS Growth
- MXL N/A
- TVTX N/A
- EPS
- MXL N/A
- TVTX N/A
- Revenue
- MXL $360,528,000.00
- TVTX $233,175,000.00
- Revenue This Year
- MXL $24.58
- TVTX $62.88
- Revenue Next Year
- MXL $19.78
- TVTX $57.60
- P/E Ratio
- MXL N/A
- TVTX N/A
- Revenue Growth
- MXL N/A
- TVTX 60.55
- 52 Week Low
- MXL $11.08
- TVTX $5.12
- 52 Week High
- MXL $26.59
- TVTX $25.29
- Technical
- Relative Strength Index (RSI)
- MXL 41.31
- TVTX 53.52
- Support Level
- MXL $15.59
- TVTX $22.48
- Resistance Level
- MXL $17.43
- TVTX $23.69
- Average True Range (ATR)
- MXL 0.92
- TVTX 1.22
- MACD
- MXL -0.07
- TVTX -0.02
- Stochastic Oscillator
- MXL 30.33
- TVTX 41.10
About MXL MaxLinear Inc.
MaxLinear Inc is a provider of radio frequency and mixed-signal integrated circuits for cable and satellite broadband communications, the connected home, and for data center, metro, and long-haul fiber networks. The company's radio frequency receiver products capture and process digital and analog broadband signals to be decoded for various applications. MaxLinear's product options include both radio frequency receivers and radio frequency receiver systems-on-chips. The company's products enable the distribution and display of broadband video and data content in a wide range of electronic devices. Customers for MaxLinear include original equipment manufacturers, module makers, and original design manufacturers.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often cause end-stage kidney disease.